Cargando…

Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discovery

Although the initial outbreaks of the deadly coronavirus that causes severe acute respiratory syndrome (SARS-CoV) were controlled by public health measures, the development of vaccines and antiviral agents for SARS-CoV is essential for improving control and treatment of future outbreaks. One potenti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grum-Tokars, Valerie, Ratia, Kiira, Begaye, Adrian, Baker, Susan C., Mesecar, Andrew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036818/ https://www.ncbi.nlm.nih.gov/pubmed/17397958 http://dx.doi.org/10.1016/j.virusres.2007.02.015

Ejemplares similares

Coronavirus Papain-like Peptidases
por: Ratia, Kiira, et al.
Publicado: (2013)

Deubiquitinating Activity of the SARS-CoV Papain-Like Protease
por: Barretto, Naina, et al.
Publicado: (2006)

Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating Activity of SARS-CoV Papain-Like Protease
por: Ratia, Kiira, et al.
Publicado: (2014)

Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors
por: Ghosh, Arun K., et al.
Publicado: (2007)

Nidovirus papain-like proteases: Multifunctional enzymes with protease, deubiquitinating and deISGylating activities
por: Mielech, Anna M., et al.
Publicado: (2014)

Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors
por: Ghosh, Arun K., et al.
Publicado: (2008)

The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
por: Báez-Santos, Yahira M., et al.
Publicado: (2015)

Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding
por: Turlington, Mark, et al.
Publicado: (2013)

Discovery of Selective Inhibitors of the Clostridium difficile Dehydroquinate Dehydratase
por: Ratia, Kiira, et al.
Publicado: (2014)

X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility for structure-based drug design
por: Clasman, Jozlyn R., et al.
Publicado: (2017)

MERS-CoV papain-like protease has deISGylating and deubiquitinating activities
por: Mielech, Anna M., et al.
Publicado: (2014)

X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases
por: Báez-Santos, Yahira M., et al.
Publicado: (2014)

Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4—The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS)
por: St. John, Sarah E., et al.
Publicado: (2015)

Identifying small molecule probes of ENTPD5 through high throughput screening
por: Durst, Matthew A., et al.
Publicado: (2019)

Structural Insights into the Interaction of Coronavirus Papain-Like Proteases and Interferon-Stimulated Gene Product 15 from Different Species
por: Daczkowski, Courtney M., et al.
Publicado: (2017)

Catalytic function and substrate specificity of alpha and beta coronavirus papain-like proteases: targeting human NL63, SARS-CoV and SARS-CoV-2 (Covid-19) with designed inhibitors
por: Chapman, Mackenzie E., et al.
Publicado: (2022)

Progress in Anti-SARS Coronavirus Chemistry, Biology and Chemotherapy
por: Ghosh, Arun K., et al.
Publicado: (2006)

Inhibition of Aβ(42) oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs
por: Park, Sei-Kyoung, et al.
Publicado: (2016)

Protocol for in vitro fluorescence assay of papain-like protease and cell-based immunofluorescence assay of coronavirus infection
por: Chang, JuOae, et al.
Publicado: (2023)

Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches
por: Alamri, Mubarak A., et al.
Publicado: (2020)

Decoupling deISGylating and deubiquitinating activities of the MERS virus papain-like protease
por: Clasman, Jozlyn R., et al.
Publicado: (2020)

Recent progress in the discovery of inhibitors targeting coronavirus proteases
por: Wang, Haofeng, et al.
Publicado: (2016)

X-Ray Structure and Inhibition of 3C-like Protease from Porcine Epidemic Diarrhea Virus
por: St. John, Sarah E., et al.
Publicado: (2016)

The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species
por: Niemeyer, Daniela, et al.
Publicado: (2018)

Mutational and inhibitive analysis of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer-based assays
por: Kuang, Wan-Fen, et al.
Publicado: (2005)

Proteases of SARS Coronaviruses
por: Mukherjee, Rukmini, et al.
Publicado: (2023)

Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease
por: Lindner, Holger A., et al.
Publicado: (2007)

QSAR modeling and pharmacoinformatics of SARS coronavirus 3C-like protease inhibitors
por: Ishola, Ahmed Adebayo, et al.
Publicado: (2021)

Identification of Quorum-Sensing Inhibitors Disrupting Signaling between Rgg and Short Hydrophobic Peptides in Streptococci
por: Aggarwal, Chaitanya, et al.
Publicado: (2015)

Efficiency Improvements and Discovery of New Substrates for a SARS-CoV-2 Main Protease FRET Assay
por: Dražić, Tonko, et al.
Publicado: (2021)

In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2
por: Bhattacharya, Kunal, et al.
Publicado: (2022)

Analysis of Coronavirus Temperature-Sensitive Mutants Reveals an Interplay between the Macrodomain and Papain-Like Protease Impacting Replication and Pathogenesis
por: Deng, Xufang, et al.
Publicado: (2019)

Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and FlipGFP-based reporter assay
por: Xia, Zilei, et al.
Publicado: (2021)

Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors
por: Ramajayam, R., et al.
Publicado: (2010)

Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus
por: Hartini, Yustina, et al.
Publicado: (2021)

Structural and functional characterization of MERS coronavirus papain-like protease
por: Lin, Min-Han, et al.
Publicado: (2014)

Targeting papain-like protease for broad-spectrum coronavirus inhibition
por: Yuan, Shuofeng, et al.
Publicado: (2022)

Two Inhibitors Against the 3C-Like Proteases of Swine Coronavirus and Feline Coronavirus
por: Zhou, Mengxin, et al.
Publicado: (2021)

Ligand-based discovery of coronavirus main protease inhibitors using MACAW molecular embeddings
por: Dong, Jie, et al.
Publicado: (2022)

Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay
por: Ma, Chunlong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6gsodsvs6pjkmjid8u3g1q9n6b